Media Database
>
Rachael Robertson

Rachael Robertson

Enterprise & Investigative Writer at MedPage Today

Contact this person
Email address
r*****@*******.comGet email address
Influence score
56
Phone
(XXX) XXX-XXXX Get mobile number
Location
United States
Languages
  • English
Covering topics
  • Investigative Reporting

View more media outlets and journalists by signing up to Prowly

View latest data and reach out all from one place
Sign up for free

Recent Articles

medpagetoday.com

USPSTF Plans Changes to Cervical Cancer Screening Recommendations

Self-collected HPV testing is a new addition
medpagetoday.com

Should Pharmaceutical Companies Sell Weight-Loss Drugs Directly to ...

Physicians, policymakers raise questions about LillyDirect connecting patients with telehealth
medpagetoday.com

Want to Limit Respiratory Virus Infections? Mask and Test in Hospitals

Healthcare workers masking makes a difference, study found
medpagetoday.com

Severe Maternal Morbidity at First Birth Linked to Lower Subsequent...

Traumatic experiences in pregnancy, delivery can shape reproductive decisions, authors say
medpagetoday.com

Genetic Carrier Screening Changed Couples' Reproductive Decision Ma...

Australian study explored screening for hundreds of genetic conditions
medpagetoday.com

MedPod Today: What Happens to Healthcare Under Trump?

MedPage Today reporters offer further insights into recently covered topics
medpagetoday.com

Trump's Age: Is It a Risk?

Gerontology experts weigh in
medpagetoday.com

Physicians Rarely Disciplined by Medical Boards for Spreading Misin...

Editorialists say sanctions should be rare and discipline may be better left to other agencies
medpagetoday.com

Very Early Abortion Non-Inferior to Standard Medication Abortion Ti...

Trial confirms what previous observational studies have found
medpagetoday.com

Physician Explores Family's End-of-Life Journey in New Podcast

'There were so many places that we ran into unexpected obstacles'
medpagetoday.com

GLP-1 Drugs Tied to Reduced Risk of Uterine Fibroids

GLP-1 receptor agonists may have better protective benefits versus metformin, insulin